Shah Pratik

President, CEO and Chairperson at Design Therapeutics, Inc. · on record since Mar 25, 2021
Director at TRANZYME INC · on record since Jul 17, 2013
10% owner at TRANZYME INC · on record since Jul 17, 2013
Director at Auspex Pharmaceuticals, Inc. · on record since Feb 12, 2014
President and CEO at Auspex Pharmaceuticals, Inc. · on record since Feb 12, 2014
Director at THORATEC CORP · on record since Dec 6, 2018
Director at Design Therapeutics, Inc. · on record since Mar 25, 2021
Director at ARS Pharmaceuticals, Inc. · on record since Nov 10, 2022
10% owner at ARS Pharmaceuticals, Inc. · on record since Nov 10, 2022

Insider trading activity of Shah Pratik

Transactions on record: 37; since Dec 23, 2013

Open-market buys: 2; $600K

Open-market sells: 0

Companies traded: 5; last filing Jun 26, 2026

Figures computed from official regulatory filings — methodology.

Companies where Shah Pratik has traded

ARS Pharmaceuticals, Inc.14 tx · Jun 26, 2026
Design Therapeutics, Inc.12 tx · $500K · Jan 5, 2026
THORATEC CORP3 tx · $4.8M · Jan 24, 2020
Auspex Pharmaceuticals, Inc.7 tx · $100K · May 6, 2015
TRANZYME INC1 tx · Dec 23, 2013

Track record of Shah Pratik

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Shah Pratik

Co-insiders of Shah Pratik

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
ARS Pharmaceuticals, Inc.	Jun 26, 2026	AwardD	30,000	0.00 USD	—	SEC
Design Therapeutics, Inc.	Jan 5, 2026	AwardD	750,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Dec 11, 2025	AwardD	525,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Dec 11, 2025	AwardD	525,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Nov 14, 2025	Gift	-250,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Nov 14, 2025	Gift	-100,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 27, 2025	AwardD	30,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Jan 6, 2025	AwardD	600,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 24, 2024	AwardD	40,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 17, 2024	Gift	-200,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 17, 2024	Gift	-1,132,900	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 7, 2024	Gift	-1,332,950	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 6, 2024	Other	-2,665,800	—	—	SEC
ARS Pharmaceuticals, Inc.	Jun 6, 2024	Gift	1,332,900	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 6, 2024	Gift	-1,332,900	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Sep 5, 2023	AwardD	1,050,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Sep 5, 2023	AwardD	525,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Sep 5, 2023	AwardD	525,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 28, 2023	AwardD	40,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Feb 3, 2023	AwardD	415,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Nov 10, 2022	Award	10,156,204	—	—	SEC
ARS Pharmaceuticals, Inc.	Nov 10, 2022	AwardD	354,570	—	—	SEC
Design Therapeutics, Inc.	Feb 2, 2022	AwardD	475,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Apr 1, 2021	OtherD	-171,025	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Apr 1, 2021	Buy	25,000	20.00 USD	$500K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ARS Pharmaceuticals, Inc.	Jun 26, 2026	AwardD	30,000	0.00 USD	—	SEC
Design Therapeutics, Inc.	Jan 5, 2026	AwardD	750,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Dec 11, 2025	AwardD	525,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Dec 11, 2025	AwardD	525,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Nov 14, 2025	Gift	-250,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Nov 14, 2025	Gift	-100,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 27, 2025	AwardD	30,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Jan 6, 2025	AwardD	600,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 24, 2024	AwardD	40,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 17, 2024	Gift	-200,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 17, 2024	Gift	-1,132,900	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 7, 2024	Gift	-1,332,950	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 6, 2024	Other	-2,665,800	—	—	SEC
ARS Pharmaceuticals, Inc.	Jun 6, 2024	Gift	1,332,900	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 6, 2024	Gift	-1,332,900	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Sep 5, 2023	AwardD	1,050,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Sep 5, 2023	AwardD	525,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Sep 5, 2023	AwardD	525,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Jun 28, 2023	AwardD	40,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Feb 3, 2023	AwardD	415,000	0.00 USD	$0	SEC
ARS Pharmaceuticals, Inc.	Nov 10, 2022	Award	10,156,204	—	—	SEC
ARS Pharmaceuticals, Inc.	Nov 10, 2022	AwardD	354,570	—	—	SEC
Design Therapeutics, Inc.	Feb 2, 2022	AwardD	475,000	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Apr 1, 2021	OtherD	-171,025	0.00 USD	$0	SEC
Design Therapeutics, Inc.	Apr 1, 2021	Buy	25,000	20.00 USD	$500K	SEC